Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitschak Storosum

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature|October 28, 2005
Later results don't confirm antidepressant suicide linkTamar Wohlfarth, Jitschak Storosum
Lancet (London, England)|January 26, 2002
Informed consent from behaviourally disturbed patientsJitschak Storosum, Barbara van Zwieten, Lieuwe de Haan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trialsTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2014
Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysisTaina Mattila, Tamar Wohlfarth, Maarten Koeter, et al.
Schizophrenia Bulletin|December 22, 2014
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophreniaTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature|October 28, 2005
Later results don't confirm antidepressant suicide linkTamar Wohlfarth, Jitschak Storosum
Lancet (London, England)|January 26, 2002
Informed consent from behaviourally disturbed patientsJitschak Storosum, Barbara van Zwieten, Lieuwe de Haan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trialsTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2014
Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysisTaina Mattila, Tamar Wohlfarth, Maarten Koeter, et al.
Schizophrenia Bulletin|December 22, 2014
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophreniaTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Pageof 1